These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9461033)

  • 1. Triphenylethylene antiestrogens induce uterine vascular endothelial growth factor expression via their partial estrogen agonist activity.
    Hyder SM; Chiappetta C; Stancel GM
    Cancer Lett; 1997 Dec; 120(2):165-71. PubMed ID: 9461033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterine expression of vascular endothelial growth factor is increased by estradiol and tamoxifen.
    Hyder SM; Stancel GM; Chiappetta C; Murthy L; Boettger-Tong HL; Makela S
    Cancer Res; 1996 Sep; 56(17):3954-60. PubMed ID: 8752163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of estrogen-regulated gene expression in vivo by the pure antiestrogen ICI 182,780.
    Hyder SM; Chiappetta C; Murthy L; Stancel GM
    Cancer Res; 1997 Jul; 57(13):2547-9. PubMed ID: 9205050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-related effects of a triphenylethylene antiestrogen on estrogen-induced changes in uterine weight, estrogen receptors, and endometrial sensitivity in rats.
    Trivedi RN; Chauhan SC; Dwivedi A; Kamboj VP; Singh MM
    Contraception; 1995 Jun; 51(6):367-79. PubMed ID: 7554978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells.
    Ruohola JK; Valve EM; Karkkainen MJ; Joukov V; Alitalo K; Härkönen PL
    Mol Cell Endocrinol; 1999 Mar; 149(1-2):29-40. PubMed ID: 10375015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of estrogen target genes and growth by selective estrogen-receptor modulators in endometrial cancer cells.
    Dardes RC; Schafer JM; Pearce ST; Osipo C; Chen B; Jordan VC
    Gynecol Oncol; 2002 Jun; 85(3):498-506. PubMed ID: 12051881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro regulation of vascular endothelial growth factor by estrogens and antiestrogens in estrogen-receptor positive breast cancer.
    Takei H; Lee ES; Jordan VC
    Breast Cancer; 2002; 9(1):39-42. PubMed ID: 12196720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential sensitivity of rat uterine growth and epithelium hypertrophy to estrogens and antiestrogens.
    Branham WS; Zehr DR; Sheehan DM
    Proc Soc Exp Biol Med; 1993 Jul; 203(3):297-303. PubMed ID: 8516342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen stimulates expression of the c-fos proto-oncogene in rodent uterus.
    Kirkland JL; Murthy L; Stancel GM
    Mol Pharmacol; 1993 May; 43(5):709-14. PubMed ID: 8502228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of antiestrogens with human breast cancer in long-term tissue culture.
    Lippman M; Bolan G; Huff K
    Cancer Treat Rep; 1976 Oct; 60(10):1421-9. PubMed ID: 1035504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparate effects of triphenylethylene antiestrogens on estrogen and progestin biosyntheses by cultured rat granulosa cells.
    Welsh TH; Jia XC; Jones PB; Zhuang LZ; Hsueh AJ
    Endocrinology; 1984 Oct; 115(4):1275-82. PubMed ID: 6434288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of the angiogenic factor VEGF in the uterus by the antiprogestin onapristone.
    Hyder SM; Chiappetta C; Stancel GM
    Cancer Lett; 2000 Aug; 156(1):101-7. PubMed ID: 10840165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of vascular endothelial growth factor expression by estrogens and progestins.
    Hyder SM; Huang JC; Nawaz Z; Boettger-Tong H; Mäkelä S; Chiappetta C; Stancel GM
    Environ Health Perspect; 2000 Oct; 108 Suppl 5():785-90. PubMed ID: 11035983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats.
    Sato M; Rippy MK; Bryant HU
    FASEB J; 1996 Jun; 10(8):905-12. PubMed ID: 8666168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships of calmodulin antagonism by triphenylethylene antiestrogens.
    Barrera G; Screpanti I; Paradisi L; Parola M; Ferretti C; Vacca A; Farina A; Dianzani MU; Frati L; Gulino A
    Biochem Pharmacol; 1986 Sep; 35(17):2984-6. PubMed ID: 3017367
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of angiogenesis by antiestrogens.
    Gagliardi A; Collins DC
    Cancer Res; 1993 Feb; 53(3):533-5. PubMed ID: 7678775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth.
    Cullinan-Bove K; Koos RD
    Endocrinology; 1993 Aug; 133(2):829-37. PubMed ID: 8344219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent effects of 4-hydroxytamoxifen, the active metabolite of tamoxifen, on estrogen receptor-alpha expression in the rat uterus.
    Reed CA; Berndtson AK; Nephew KP
    Anticancer Drugs; 2005 Jun; 16(5):559-67. PubMed ID: 15846122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor in the rat pituitary: differential distribution and regulation by estrogen.
    Ochoa AL; Mitchner NA; Paynter CD; Morris RE; Ben-Jonathan N
    J Endocrinol; 2000 May; 165(2):483-92. PubMed ID: 10810312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiestrogens inhibit endothelial cell growth stimulated by angiogenic growth factors.
    Gagliardi AR; Hennig B; Collins DC
    Anticancer Res; 1996; 16(3A):1101-6. PubMed ID: 8702220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.